Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,404,453 | 7,622,070 | 920,774 | 2,089,719 | 4,401,024 |
| Marketable Securities | 3,031,871 | 1,418,902 | 691,163 | 2,640,026 | 3,001,322 |
| Receivables | 11,737,310 | 10,985,560 | 10,446,800 | 10,927,900 | 9,046,744 |
| Inventories | 5,592,946 | 5,246,171 | 4,892,160 | 4,618,957 | 4,311,964 |
| Other current assets | 0 | 340,547 | 2 | -2 | -4 |
| TOTAL | $28,766,580 | $25,613,250 | $16,950,900 | $20,276,600 | $20,761,050 |
| Non-Current Assets | |||||
| PPE Net | 17,663,240 | 15,870,110 | 14,302,290 | 13,207,540 | 11,893,310 |
| Investments And Advances | 301,728 | 239,394 | 240,386 | 241,468 | 214,766 |
| Intangibles | 8,031,531 | 8,008,794 | 8,683,584 | 8,770,951 | 8,135,996 |
| Other Non-Current Assets | 3,819,721 | 3,570,422 | 3,345,740 | 3,166,811 | 2,809,618 |
| TOTAL | $29,816,220 | $27,688,720 | $26,572,000 | $25,386,770 | $23,053,690 |
| Total Assets | $58,582,800 | $53,301,970 | $43,522,900 | $45,663,370 | $43,814,750 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 813,648 | 786,724 | 1,479,878 | 940,606 | 965,498 |
| Accounts payable and accrued liabilities | 3,549,245 | 4,294,224 | 1,893,674 | 3,717,991 | 2,935,476 |
| Other current liabilities | 24,189,520 | 21,182,090 | 19,870,320 | 18,942,070 | 19,496,260 |
| TOTAL | $30,711,970 | $27,115,270 | $24,112,230 | $24,633,910 | $25,192,590 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,584,025 | 7,447,034 | 2,440,838 | 2,980,666 | 2,908,904 |
| aiOther Non-Current Liabilities | 1,246,118 | 1,198,700 | 1,161,306 | 1,100,616 | 985,354 |
| TOTAL | $10,105,890 | $9,949,773 | $5,009,222 | $5,556,804 | $5,045,468 |
| Total Liabilities | $40,817,860 | $37,065,040 | $29,121,460 | $30,190,710 | $30,238,060 |
| Shareholders' Equity | |||||
| Common Shares | 65,740 | 64,358 | 65,666 | 65,485 | 65,846 |
| Retained earnings | 17,934,160 | 16,183,250 | 14,421,680 | 15,222,620 | 13,393,310 |
| Other shareholders' equity | -234,960 | -10,688 | -84,906 | 185,555 | 118,534 |
| TOTAL | $17,764,940 | $16,236,920 | $14,401,440 | $15,472,660 | $13,576,690 |
| Total Liabilities And Equity | $58,582,800 | $53,301,960 | $43,522,900 | $45,663,370 | $43,814,750 |